{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:48:20Z","timestamp":1788922100619,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14820-4","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T04:53:09Z","timestamp":1756183989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Co-administration of low-dose-Naltrexone and Carbamazepine remarkedly ameliorate allodynia and cognitive deficit in a rat model of trigeminal neuralgia"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-5849","authenticated-orcid":false,"given":"Yeganeh","family":"Naderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monavareh","family":"Soti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi A.","family":"Kohlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"7","key":"14820_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/head.12384","volume":"54","author":"S Maarbjerg","year":"2014","unstructured":"Maarbjerg, S., Gozalov, A., Olesen, J. & Bendtsen, L. Concomitant persistent pain in classical trigeminal neuralgia\u2013evidence for different subtypes. Headache: J. Head Face Pain. 54 (7), 1173\u20131183 (2014).","journal-title":"Headache: J. Head Face Pain"},{"issue":"5","key":"14820_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1227\/00006123-198505000-00005","volume":"16","author":"AR M\u00f8ller","year":"1985","unstructured":"M\u00f8ller, A. R. & Jannetta, P. J. Microvascular decompression in hemifacial spasm: intraoperative electrophysiological observations. Neurosurgery 16 (5), 612\u2013618 (1985).","journal-title":"Neurosurgery"},{"issue":"10","key":"14820_CR3","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1179\/1743132814Y.0000000344","volume":"36","author":"J Zhong","year":"2014","unstructured":"Zhong, J. et al. Microvascular decompression surgery: surgical principles and technical nuances based on 4000 cases. Neurol. Res. 36 (10), 882\u2013893 (2014).","journal-title":"Neurol. Res."},{"issue":"3","key":"14820_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/j.1526-4637.2009.00795.x","volume":"11","author":"Z Rudich","year":"2010","unstructured":"Rudich, Z., Lerman, S. F., Gurevich, B. & Shahar, G. Pain specialists\u2019 evaluation of patient\u2019s prognosis during the first visit predicts subsequent depression and the affective dimension of pain. Pain Med. 11 (3), 446\u2013452 (2010).","journal-title":"Pain Med."},{"key":"14820_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-015-0548-y","volume":"16","author":"T-H Wu","year":"2015","unstructured":"Wu, T-H. et al. Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study. J. Headache Pain. 16, 1\u20138 (2015).","journal-title":"J. Headache Pain"},{"issue":"4","key":"14820_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/00000658-193210000-00026","volume":"96","author":"WE Dandy","year":"1932","unstructured":"Dandy, W. E. The treatment of trigeminal neuralgia by the cerebellar route. Ann. Surg. 96 (4), 787 (1932).","journal-title":"Ann. Surg."},{"issue":"2","key":"14820_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0002-9610(34)90403-7","volume":"24","author":"WE Dandy","year":"1934","unstructured":"Dandy, W. E. Concerning the cause of trigeminal neuralgia. Am. J. Surg. 24 (2), 447\u2013455 (1934).","journal-title":"Am. J. Surg."},{"issue":"12","key":"14820_CR8","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1093\/brain\/124.12.2347","volume":"124","author":"S Love","year":"2001","unstructured":"Love, S. & Coakham, H. B. Trigeminal neuralgia: pathology and pathogenesis. Brain 124 (12), 2347\u20132360 (2001).","journal-title":"Brain"},{"issue":"10","key":"14820_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","volume":"15","author":"G Cruccu","year":"2008","unstructured":"Cruccu, G. et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur. J. Neurol. 15 (10), 1013\u20131028 (2008).","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"14820_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-015-0563-z","volume":"16","author":"E Besi","year":"2015","unstructured":"Besi, E., Boniface, D., Cregg, R. & Zakrzewska, J. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool adverse events profile (AEP). J. Headache Pain. 16 (1), 1\u20137 (2015).","journal-title":"J. Headache Pain"},{"key":"14820_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-015-0563-z","volume":"16","author":"E Besi","year":"2015","unstructured":"Besi, E., Boniface, D., Cregg, R. & Zakrzewska, J. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool adverse events profile (AEP). J. Headache Pain. 16, 1\u20137 (2015).","journal-title":"J. Headache Pain"},{"key":"14820_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1129-2377-15-34","volume":"15","author":"G Di Stefano","year":"2014","unstructured":"Di Stefano, G., La Cesa, S., Truini, A. & Cruccu, G. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J. Headache Pain. 15, 1\u20135 (2014).","journal-title":"J. Headache Pain"},{"key":"14820_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","volume":"33","author":"J Younger","year":"2014","unstructured":"Younger, J., Parkitny, L. & McLain, D. The use of low-dose Naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin. Rheumatol. 33, 451\u2013459 (2014).","journal-title":"Clin. Rheumatol."},{"issue":"10","key":"14820_CR14","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1177\/1049909119838974","volume":"36","author":"D Trofimovitch","year":"2019","unstructured":"Trofimovitch, D. & Baumrucker, S. J. Pharmacology update: low-dose Naltrexone as a possible nonopioid modality for some chronic, nonmalignant pain syndromes. Am. J. Hospice Palliat. Medicine\u00ae. 36 (10), 907\u2013912 (2019).","journal-title":"Am. J. Hospice Palliat. Medicine\u00ae"},{"key":"14820_CR15","doi-asserted-by":"publisher","first-page":"135248","DOI":"10.1016\/j.neulet.2020.135248","volume":"736","author":"CL de Oliveira","year":"2020","unstructured":"de Oliveira, C. L. et al. Low-dose Naltrexone reverses facial mechanical allodynia in a rat model of trigeminal neuralgia. Neurosci. Lett. 736, 135248 (2020).","journal-title":"Neurosci. Lett."},{"issue":"8","key":"14820_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/ddr.21409","volume":"78","author":"JB Pineda-Farias","year":"2017","unstructured":"Pineda-Farias, J. B., Caram-Salas, N. L., Salinas-Abarca, A. B., Ocampo, J. & Granados-Soto, V. Ultra-Low doses of Naltrexone enhance the antiallodynic effect of Pregabalin or Gabapentin in neuropathic rats. Drug Dev. Res. 78 (8), 371\u2013380. https:\/\/doi.org\/10.1002\/ddr.21409 (2017).","journal-title":"Drug Dev. Res."},{"issue":"4","key":"14820_CR17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/epi.14680","volume":"60","author":"HL Grabenstatter","year":"2019","unstructured":"Grabenstatter, H. L. & Dudek, F. E. Effect of carbamazepine on spontaneous recurrent seizures recorded from the dentate gyrus in rats with kainate-induced epilepsy. Epilepsia 60 (4), 636\u2013647 (2019).","journal-title":"Epilepsia"},{"key":"14820_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.npep.2016.06.003","volume":"59","author":"DI Tawfik","year":"2016","unstructured":"Tawfik, D. I. et al. Evaluation of therapeutic effect of low dose Naltrexone in experimentally-induced crohn\u2019s disease in rats. Neuropeptides 59, 39\u201345 (2016).","journal-title":"Neuropeptides"},{"issue":"8","key":"14820_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jpain.2017.02.427","volume":"18","author":"W Ding","year":"2017","unstructured":"Ding, W. et al. An improved rodent model of trigeminal neuropathic pain by unilateral chronic constriction injury of distal infraorbital nerve. J. Pain. 18 (8), 899\u2013907 (2017).","journal-title":"J. Pain"},{"issue":"1","key":"14820_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","volume":"33","author":"GJ Bennett","year":"1988","unstructured":"Bennett, G. J. & Xie, Y-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1), 87\u2013107 (1988).","journal-title":"Pain"},{"issue":"10","key":"14820_CR21","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/00207454.2019.1595616","volume":"129","author":"M Liu","year":"2019","unstructured":"Liu, M., Zhong, J., Xia, L., Dou, N. & Li, S. The expression of voltage-gated sodium channels in trigeminal nerve following chronic constriction injury in rats. Int. J. Neurosci. 129 (10), 955\u2013962 (2019).","journal-title":"Int. J. Neurosci."},{"key":"14820_CR22","first-page":"e53167","volume":"103","author":"K Deseure","year":"2015","unstructured":"Deseure, K. & Hans, G. H. Chronic constriction injury of the rat\u2019s infraorbital nerve (IoN-CCI) to study trigeminal neuropathic pain. JoVE (Journal Visualized Experiments). 103, e53167 (2015).","journal-title":"JoVE (Journal Visualized Experiments)"},{"key":"14820_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-020-01174-7","volume":"21","author":"J Islam","year":"2020","unstructured":"Islam, J. et al. Optogenetic stimulation of the motor cortex alleviates neuropathic pain in rats of infraorbital nerve injury with\/without CGRP knock-down. J. Headache Pain. 21, 1\u201313 (2020).","journal-title":"J. Headache Pain"},{"key":"14820_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neulet.2019.04.017","volume":"704","author":"F Mohammadi","year":"2019","unstructured":"Mohammadi, F., Esfahlani, M. A. & Shabani, M. Erythropoietin ameliorates harmaline-induced essential tremor and cognition disturbances. Neurosci. Lett. 704, 153\u2013158 (2019).","journal-title":"Neurosci. Lett."},{"key":"14820_CR25","unstructured":"Mansoori, M. et al. Chronic migraine caused a higher rate of tendency to cannabinoid agonist compared to morphine. Acta Bio Medica: Atenei Parmensis 91(4), e2020185 (2020)."},{"issue":"1","key":"14820_CR26","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1038\/s41598-023-33016-2","volume":"13","author":"M Shabani","year":"2023","unstructured":"Shabani, M., Ilaghi, M., Naderi, R. & Razavinasab, M. The hyperexcitability of laterodorsal tegmentum cholinergic neurons accompanies adverse behavioral and cognitive outcomes of prenatal stress. Sci. Rep. 13 (1), 6011 (2023).","journal-title":"Sci. Rep."},{"issue":"4\u20135","key":"14820_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan, J. F., Mombereau, C. & Vassout, A. The tail suspension test as a model for assessing antidepressant activity: review of Pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev.. 29 (4\u20135), 571\u2013625 (2005).","journal-title":"Neurosci. Biobehavioral Reviews"},{"key":"14820_CR28","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1590\/0004-282X20160131","volume":"74","author":"Z Rajaei","year":"2016","unstructured":"Rajaei, Z., Hosseini, M. & Alaei, H. Effects of Crocin on brain oxidative damage and aversive memory in a 6-OHDA model of parkinson\u2019s disease. Arq. Neuropsiquiatr. 74, 723\u2013729 (2016).","journal-title":"Arq. Neuropsiquiatr."},{"key":"14820_CR29","unstructured":"Patel, N. M., Jozsa, F. & Das, J. M. Neuroanatomy, Spinal Trigeminal Nucleus (StatPearls Publishing, 2022)."},{"issue":"1","key":"14820_CR30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00002508-200201000-00004","volume":"18","author":"SH Sindrup","year":"2002","unstructured":"Sindrup, S. H. & Jensen, T. S. Pharmacotherapy of trigeminal neuralgia. Clin. J. Pain. 18 (1), 22\u201327 (2002).","journal-title":"Clin. J. Pain"},{"key":"14820_CR31","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1007\/s10620-011-1653-7","volume":"56","author":"JP Smith","year":"2011","unstructured":"Smith, J. P. et al. Therapy with the opioid antagonist Naltrexone promotes mucosal healing in active crohn\u2019s disease: a randomized placebo-controlled trial. Dig. Dis. Sci. 56, 2088\u20132097 (2011).","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"14820_CR32","first-page":"2","volume":"91","author":"L Reisner","year":"2001","unstructured":"Reisner, L. & Pettengill, C. A. The use of anticonvulsants in orofacial pain. oral surgery, oral medicine, oral pathology. Oral Radiol. Endodontology. 91 (1), 2\u20137 (2001).","journal-title":"Oral Radiol. Endodontology"},{"issue":"7586","key":"14820_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/bmj.39085.614792.BE","volume":"334","author":"L Bennetto","year":"2007","unstructured":"Bennetto, L., Patel, N. K. & Fuller, G. Trigeminal neuralgia and its management. Bmj 334 (7586), 201\u2013205 (2007).","journal-title":"Bmj"},{"key":"14820_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-015-0563-z","author":"E Besi","year":"2015","unstructured":"Besi, E., Boniface, D. R., Cregg, R. & Zakrzewska, J. M. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool adverse events profile (AEP). J. Headache Pain. https:\/\/doi.org\/10.1186\/s10194-015-0563-z (2015).","journal-title":"J. Headache Pain"},{"issue":"2","key":"14820_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1001\/archneur.1968.00480020015001","volume":"19","author":"JM Killian","year":"1968","unstructured":"Killian, J. M. & Fromm, G. H. Carbamazepine in the treatment of neuralgia. Use of side effects. Arch. Neurol. 19 (2), 129\u2013136. https:\/\/doi.org\/10.1001\/archneur.1968.00480020015001 (1968).","journal-title":"Arch. Neurol."},{"issue":"663","key":"14820_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/pgmj.57.663.16","volume":"57","author":"JC Taylor","year":"1981","unstructured":"Taylor, J. C., Brauer, S. & Espir, M. L. Long-term treatment of trigeminal neuralgia with carbamazepine. Postgrad. Med. J. 57 (663), 16\u201318. https:\/\/doi.org\/10.1136\/pgmj.57.663.16 (1981).","journal-title":"Postgrad. Med. J."},{"issue":"1\u20132","key":"14820_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.pain.2006.01.019","volume":"122","author":"JM Terner","year":"2006","unstructured":"Terner, J. M., Barrett, A. C., Lomas, L. M., Negus, S. S. & Picker, M. J. Influence of low doses of Naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains. PAIN\u00ae 122 (1\u20132), 90\u2013101 (2006).","journal-title":"PAIN\u00ae"},{"issue":"8","key":"14820_CR38","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/ddr.21409","volume":"78","author":"JB Pineda-Farias","year":"2017","unstructured":"Pineda-Farias, J. B., Caram\u2010Salas, N. L., Salinas\u2010Abarca, A. B., Ocampo, J. & Granados\u2010Soto, V. Ultra\u2010low doses of Naltrexone enhance the antiallodynic effect of Pregabalin or Gabapentin in neuropathic rats. Drug Dev. Res. 78 (8), 371\u2013380 (2017).","journal-title":"Drug Dev. Res."},{"issue":"2","key":"14820_CR39","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/jpet.300.2.588","volume":"300","author":"KJ Powell","year":"2002","unstructured":"Powell, K. J. et al. Paradoxical effects of the opioid antagonist Naltrexone on morphine analgesia, tolerance, and reward in rats. J. Pharmacol. Exp. Ther. 300 (2), 588\u2013596. https:\/\/doi.org\/10.1124\/jpet.300.2.588 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"14820_CR40","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/00008877-200512000-00001","volume":"16","author":"J Paquette","year":"2005","unstructured":"Paquette, J. & Olmstead, M. Ultra-low dose Naltrexone enhances cannabinoid-induced antinociception. Behav. Pharmacol. 16 (8), 597\u2013603 (2005).","journal-title":"Behav. Pharmacol."},{"key":"14820_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fnhum.2018.00107","volume":"12","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. Dysregulation of pain-and emotion-related networks in trigeminal neuralgia. Front. Hum. Neurosci. 12, 107 (2018).","journal-title":"Front. Hum. Neurosci."},{"issue":"6","key":"14820_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1159\/000256666","volume":"84","author":"M Rezvanfard","year":"2009","unstructured":"Rezvanfard, M., Zarrindast, M-R. & Bina, P. Role of ventral hippocampal GABAA and NMDA receptors in the anxiolytic effect of carbamazepine in rats using the elevated plus maze test. Pharmacology 84 (6), 356\u2013366 (2009).","journal-title":"Pharmacology"},{"issue":"4","key":"14820_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1528-1157.1995.tb01018.x","volume":"36","author":"S Sudha","year":"1995","unstructured":"Sudha, S., Lakshmana, M. K. & Pradhan, N. Changes in learning and memory, acetylcholinesterase activity and monoamines in brain after chronic carbamazepine administration in rats. Epilepsia 36 (4), 416\u2013422 (1995).","journal-title":"Epilepsia"},{"key":"14820_CR44","doi-asserted-by":"publisher","unstructured":"Canli, T., Cook, R. G. & Miczek, K. A. Opiate antagonists enhance the working memory of rats in the radial maze. Pharmacol Biochem. Behav 36(3), 521\u2013525 https:\/\/doi.org\/10.1016\/0091-3057(90)90250-l (1990).","DOI":"10.1016\/0091-3057(90)90250-l"},{"key":"14820_CR45","doi-asserted-by":"publisher","first-page":"174480692090189","DOI":"10.1177\/1744806920901890","volume":"16","author":"E Gambeta","year":"2020","unstructured":"Gambeta, E., Chichorro, J. G. & Zamponi, G. W. Trigeminal neuralgia: an overview from pathophysiology to Pharmacological treatments. Mol. Pain. 16, 1744806920901890 (2020).","journal-title":"Mol. Pain"},{"issue":"2","key":"14820_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbi.2006.10.011","volume":"21","author":"LR Watkins","year":"2007","unstructured":"Watkins, L. R. et al. Glia as the bad guys: implications for improving clinical pain control and the clinical utility of opioids. Brain. Behav. Immun. 21 (2), 131\u2013146 (2007).","journal-title":"Brain. Behav. Immun."},{"issue":"8","key":"14820_CR47","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jpain.2008.03.005","volume":"9","author":"TM Largent-Milnes","year":"2008","unstructured":"Largent-Milnes, T. M., Guo, W., Wang, H-Y., Burns, L. H. & Vanderah, T. W. Oxycodone plus ultra-low-dose Naltrexone attenuates neuropathic pain and associated \u00b5-opioid receptor\u2013Gs coupling. J. Pain. 9 (8), 700\u2013713 (2008).","journal-title":"J. Pain"},{"issue":"4","key":"14820_CR48","first-page":"82","volume":"6","author":"K Toljan","year":"2018","unstructured":"Toljan, K. & Vrooman, B. Low-dose Naltrexone (LDN)\u2014review of therapeutic utilization. Med. Sci. 6 (4), 82 (2018).","journal-title":"Med. Sci."},{"issue":"4","key":"14820_CR49","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1124\/mol.113.086496","volume":"84","author":"Z Zhang","year":"2013","unstructured":"Zhang, Z., Wang, X., Wang, W., Lu, Y-G. & Pan, Z. Z. Brain-Derived neurotrophic Factor\u2013Mediated downregulation of brainstem K+\u2013Cl\u2013Cotransporter and Cell-Type\u2013Specific GABA impairment for activation of descending pain facilitation. Mol. Pharmacol. 84 (4), 511\u2013520 (2013).","journal-title":"Mol. Pharmacol."},{"key":"14820_CR50","doi-asserted-by":"publisher","first-page":"120101","DOI":"10.1016\/j.jns.2021.120101","volume":"434","author":"PK Eide","year":"2022","unstructured":"Eide, P. K. Familial occurrence of classical and idiopathic trigeminal neuralgia. J. Neurol. Sci. 434, 120101 (2022).","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"14820_CR51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5055\/jom.2007.0051","volume":"3","author":"S Hamann","year":"2007","unstructured":"Hamann, S. & Sloan, P. Oral Naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study. J. Opioid Manag. 3 (3), 137\u2013144 (2007).","journal-title":"J. Opioid Manag."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14820-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14820-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14820-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T23:01:46Z","timestamp":1757458906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14820-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14820"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14820-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments were done in accordance with the ARRIVE guidelines and National Institutes of Health Guide for the Care and Use of Laboratory Animals) NIH Publication No. 80\u201323, revised 1996). All procedures were approved (91000056) by the Research and Ethics Committee of Kerman Universities of Medical Sciences, Kerman, Iran. All experiments were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}}],"article-number":"31335"}}